Who Is Eligible for Potentially Life-Saving RSV Jab in NI

Who is eligible for potentially life-saving RSV jab in NI

It was introduced to help protect newborns and infants through the vaccination of pregnant women

GSK Plc seeks EMA approval for RSV vaccine in adults 18+

GSK plc (LON/NYSE: GSK) has announced that the European Medicines Agency (EMA) has accepted the company’s regulatory application to expand the use of its adjuvanted recombinant respiratory syncytial virus (RSV) vaccine to include adults from 18 years of age. Arexvy was the first RSV vaccine approved in the European Economic Area for the prevention of lower respiratory tract disease (LRTD) caused by RSV in adults aged 60 and older, and for those …

Early RSV vaccination in pregnancy boosts antibody transfer to newborns

Vaccinating pregnant women at least 5 weeks before delivery significantly improves transplacental transfer of respiratory syncytial virus antibodies, offering better early protection for infants.